M&A Deal Summary |
|
---|---|
Date | 2009-04-03 |
Target | Piedmont Research Center |
Sector | Life Science |
Buyer(s) | Charles River Laboratories International |
Sellers(s) | PPD |
Deal Type | Divestiture |
Deal Value | 46M USD |
SEARCH BY
Try For Free 7-Day Free Trial
Category | Company |
---|---|
Founded | 1947 |
Sector | Life Science |
Employees | 20,400 |
Revenue | 4.1B USD (2023) |
Charles River Laboratories International is a provider of essential products and contract services to help pharmaceutical and biotechnology companies, government agencies and academic institutions around the globe accelerate their research and drug development efforts. Charles River Laboratories International was incorporated in 1947 and is based in Wilmington, Massachusetts.
DEAL STATS | # |
---|---|
Overall | 4 of 31 |
Sector (Life Science) | 4 of 28 |
Type (Divestiture) | 1 of 4 |
State (North Carolina) | 2 of 2 |
Country (United States) | 3 of 20 |
Year (2009) | 1 of 3 |
Size (of disclosed) | 13 of 17 |
DATE | TARGET | DEAL TYPE | VALUE |
---|---|---|---|
2008-09-15 |
Molecular Therapeutics
Ann Arbor, Michigan, United States Molecular Therapeutics, Inc. is a biotechnology company develops anti cancer agents. |
Buy | $13M |
DATE | TARGET | DEAL TYPE | VALUE |
---|---|---|---|
2009-07-31 |
Cerebricon Oy
Kuopio, Finland Cerebricon Oy, provides pharmaceutical discovery services foused on the central nervous system (CNS) diseases category. |
Buy | - |
Category | Company |
---|---|
Founded | 1985 |
Sector | Life Science |
Employees | 26,000 |
Revenue | 4.7B USD (2020) |
PPD is a global contract research organization providing drug discovery, development, and lifecycle management services. Its clients and partners primarily include pharmaceutical and biotechnology companies, in addition to medical device companies, academic institutions, and government organizations. With offices in 44 countries and more than 11,000 professionals worldwide, PPDI applies innovative technologies, therapeutic expertise, and a commitment to quality to help clients and partners accelerate the delivery of safe and effective therapeutics and maximize the returns on their R&D investments. PPD was founded in 1985 and is based in Wilmington, North Carolina.
DEAL STATS | # |
---|---|
Overall | 1 of 3 |
Sector (Life Science) | 1 of 3 |
Type (Divestiture) | 1 of 3 |
State (North Carolina) | 1 of 1 |
Country (United States) | 1 of 3 |
Year (2009) | 1 of 1 |
Size (of disclosed) | 1 of 1 |
DATE | TARGET | DEAL TYPE | VALUE |
---|---|---|---|
2009-04-01 |
Magen BioSciences
Waltham, Massachusetts, United States Magen BioSciences, Inc. is a provider of research and development for pharmaceutical products for the improvement of human skin. |
Buy | - |
DATE | TARGET | DEAL TYPE | VALUE |
---|---|---|---|
2009-11-06 |
Excel PharmaStudies
Beijing, China Excel PharmaStudies, Inc. is a comprehensive range of Phase II-IV clinical services, including regulatory affairs, patient recruitment, protocol design, feasibility studies, good clinical practice training and program management. |
Buy | - |